SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024201
Filing Date
2021-05-05
Accepted
2021-05-05 17:15:59
Documents
69
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 GTHX-Q1-2021 10-Q gthx-10q_20210331.htm   iXBRL 10-Q 1589312
2 EX-10.1 gthx-ex101_269.htm EX-10.1 159549
3 EX-31.1 gthx-ex311_6.htm EX-31.1 18137
4 EX-31.2 gthx-ex312_9.htm EX-31.2 17870
5 EX-32.1 gthx-ex321_10.htm EX-32.1 7286
6 EX-32.2 gthx-ex322_11.htm EX-32.2 7282
  Complete submission text file 0001564590-21-024201.txt   6546065

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA gthx-20210331.xsd EX-101.SCH 49716
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gthx-20210331_cal.xml EX-101.CAL 38417
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gthx-20210331_def.xml EX-101.DEF 154911
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gthx-20210331_lab.xml EX-101.LAB 392386
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gthx-20210331_pre.xml EX-101.PRE 290932
12 EXTRACTED XBRL INSTANCE DOCUMENT gthx-10q_20210331_htm.xml XML 1132180
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38096 | Film No.: 21894556
SIC: 2834 Pharmaceutical Preparations